Novo Nordisk posts net profit beat on Wegovy sales jump, sees growth slowdown this year

Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs.

Leave a Reply

Your email address will not be published. Required fields are marked *